Cargando…
MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
Autores principales: | Vargova, K, Pesta, M, Obrtlikova, P, Dusilkova, N, Minarik, L, Vargova, J, Berkova, A, Zemanova, Z, Michalova, K, Spacek, M, Trneny, M, Stopka, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549255/ https://www.ncbi.nlm.nih.gov/pubmed/28731457 http://dx.doi.org/10.1038/bcj.2017.63 |
Ejemplares similares
-
Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
por: Dusílková, Nina, et al.
Publicado: (2017) -
Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
por: Sochor, Marek, et al.
Publicado: (2014) -
Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer
por: Bašová, Petra, et al.
Publicado: (2017) -
Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia
por: Vargova, J, et al.
Publicado: (2016) -
Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders
por: Polgarova, Kamila, et al.
Publicado: (2017)